Treatment of BK virus with a stepwise immunosuppression reduction and intravenous immunoglobulin in pediatric kidney transplant
- 5 February 2022
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 26 (4) , e14241
Abstract
Background: BKV and BKVN are common in pediatric kidney transplant, but there is limited data on treatment approaches. Our objective was to study the prevalence of BKV and BKVN utilizing only plasma qPCR and report treatment outcomes with stepwise IR and IVIG.Methods: A retrospective study of all pediatric kidney transplants from 2013 to 2020. Excluded patients >21 years at transplant and immediate graft failure. Surveillance was conducted using only plasma BK qPCR at 1, 3, 6, 9, 12, 18, and 24 months and annually. BKV defined as ≥250 copies/ml and resolution as 10 000 copies/ml despite IR; and BKVN if confirmed on histology.Results: Fifty‐six patients were included in the study; 20 (35.7%) had BKV. BKV was associated with longer duration of stent, 40 vs. 33.5 days (p = .004). Two patients (3.5%) had confirmed, and 2(3.5%) had presumed BKVN. The first‐line treatment was IR in 100% of patients. BKVN confirmed and presumed received IVIG every month for six doses. Viral resolution was achieved in 70%, and no difference was noted in estimated glomerular filtration rate between BKV and non‐BKV group (p = .438). There were no rejection episodes, and graft survival was 100% over median follow‐up of 3 years.Conclusions: Plasma qPCR alone is adequate for screening and monitoring treatment of BKV and BKVN. A stepwise IR and IVIG resulted in BKV resolution in the majority of patients. Larger studies are required to study the role of IVIG in the treatment of BKVN.Keywords
This publication has 35 references indexed in Scilit:
- Intravenous Immunoglobulin in BK Virus NephropathyThe Open Urology & Nephrology Journal, 2014
- BK Polyomavirus in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Ureteral stent placement and BK viremia in kidney transplant recipientsTransplant Infectious Disease, 2013
- Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantationPediatric Transplantation, 2012
- Treatment of Polyomavirus Infection in Kidney Transplant Recipients: A Systematic ReviewTransplantation, 2010
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- BK Virus Nephropathy in Pediatric Renal Transplant RecipientsClinical Journal of the American Society of Nephrology, 2007
- Ureteral Stents: A Novel Risk Factor for Polyomavirus NephropathyTransplantation, 2007
- Antivirals for the treatment of polyomavirus BK replicationExpert Review of Anti-infective Therapy, 2007
- Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant RecipientsNew England Journal of Medicine, 2002